• Non ci sono risultati.

Biophotonic compositions for the treatment of otitis externa

N/A
N/A
Protected

Academic year: 2021

Condividi "Biophotonic compositions for the treatment of otitis externa"

Copied!
3
0
0

Testo completo

(1)

Page 1 of 3 Delivering a world leading IP system Phone: 1300 651 010

International: +61 2 6283 2999

www.ipaustralia.gov.au

ABN: 38 113 072 755 12 July 2018

National phase entry for patent

application

Shelston IP Pty Ltd.

L 21 60 Margaret St Sydney NSW 2000 Australia

Your reference 101300AUP00

Application number 2017207533

Applicant name Francesco Bellini, Klox Technologies Limited, Matteo Cerquetella, Adolfo Maria Tambella, Andrea Spaterna, Nikolaos Loupis, David Ohayon, Remigio Piergallini

Dear Shelston IP Pty Ltd.,

We have received your request for national phase entry for PCT application number PCT/CA2017/050032 and it has entered the national phase. The filing date is 11 January 2017 and the national phase entry date is 11 July 2018.

Please review the details on the attached application summary to ensure they are correct.

Details of this patent application can be viewed on AusPat, our Australian patent search database.

Yours sincerely, IP Australia

(2)

Page 2 of 3

Application summary

Standard patent application details

Application number: 2017207533

Title: Biophotonic compositions for the treatment of otitis externa

Your reference: 101300AUP00

Documents filed

The specification on file contains the following documents:  Description

 Claim(s)  Drawing(s)

This application currently has an abstract on file.

Applicant and inventor details

Applicant name(s) and address(es) (as it will appear on certificate/s) :

Francesco Bellini of 910- 5th Avenue S. W., Suite 2801 Calgary Alberta T2P 0C3 Canada Klox Technologies Limited of 70 Sir John Rogerson's Quay 2 Dublin Ireland

Matteo Cerquetella of School of Biosciences and Veterinary Medicine, Via Circonvallazione nn. 93/95 MC-62024 Matelica Italy

Adolfo Maria Tambella of School of Biosciences and Veterinary Medicine, Via Circonvallazione nn. 93/95 MC-62024 Matelica Italy

Andrea Spaterna of School of Biosciences and Veterinary Medicine, Via Circonvallazione, 93/95 MC-62024 Matelica Italy

Nikolaos Loupis of Kifissias 228 Avenue 14562 Kifissia Athens Greece

David Ohayon of 40 Pierre Trudeau, Dollard-des-Ormeaux Québec H9A 3J8 Canada Remigio Piergallini of Piazza Nardone, 19 AP 63036 San Benedetto del Tronto Italy

Inventor name(s): Bellini, Francesco Cerquetella, Matteo Tambella, Adolfo Maria Spaterna, Andrea Loupis, Nikolaos Ohayon, David Piergallini, Remigio

(3)

Your reference 101300AUP00

Application number 2017207533

Page 3 of 3

Agent details

Agent Name Shelston IP Pty Ltd.

Address for correspondence: L 21 60 Margaret St

Sydney NSW 2000 Australia

Address for legal service: Level 21, 60 Margaret Street Sydney NSW 2000

Australia

Priority details

Number Date Country

62/277,263 11 January 2016 US

Relevant dates

Filing date: 11 January 2017

National phase entry date: 11 July 2018

Continuation fee due: 11 January 2021

Date of patent: 11 January 2017

Riferimenti

Documenti correlati

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions..

Ebbene, lo studio tanto della fisiologia quanto della fisiopatologia di una delle condizioni più comuni di malattia cardiovascolare (i.e. lo scompenso

In questa voce rientrano le attività finanziarie che non sono classificabili nelle precedenti categorie. Vi rientrano, cioè, quegli strumenti finanziari che

This article compares the degree of regularity in the correlatives series of International Auxiliary Languages (IALs) with the correlative series of natural languages of the

Lorenzo Lombardi, Daniele Bellini, Andrea Bottoni, Matteo Calvaresi, Magda Monari, Alessandro Kovtun, Vincenzo Palermo, Manuela Melucci and Marco Bandini, Allylic and

Tyrimo metu šunis sergančius išorinės ausies uždegimu, kuriems reikalingas ausų plovimas dėl pasikartojančio išorinės ausies uždegimo ir gausių išskyrų, suskirstėme į

A hierarchy of six risk management tactics (in- cluding those not requiring communication, those requiring communication, and a lack of discernible risk management) were defined